Drugs / 18F-2-fluoro-2-deoxy-D-glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04615156 | Nov 2020 → Nov 2027 expected | lower respiratory tract disorder | Eastern Health, Canada | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-2-fluoro-2-deoxy-D-glucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04615156 ↗ |